Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis
了解 IL-27 作为新生儿败血症期间保护性免疫的负调节因子
基本信息
- 批准号:10414998
- 负责人:
- 金额:$ 49.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAnnual ReportsAnti-Inflammatory AgentsAntibiotic ResistanceAntibioticsAntibodiesBacteremiaBacteriaBacterial InfectionsBiological AssayCellsCessation of lifeChildCommunicable DiseasesCoupledDataDiseaseEscherichia coliExhibitsFrequenciesGoalsGrowthHumanIL27RA geneImmuneImmune TargetingImmune responseImmune systemImmunityImmunologicsImmunotherapeutic agentImpairmentIn VitroInfant MortalityInfectionInflammationInflammatory ResponseInterleukinsKnockout MiceKnowledgeLaboratoriesLifeLow Birth Weight InfantLungMeasuresMediatingModelingMolecularMorbidity - disease rateMusNewborn InfantOutcomePathologyPathway interactionsPenetrationPeripheralPhagocytesPhenotypePopulationPredispositionProductionProteinsPublishingReporterResearchRiskRisk FactorsSepsisSerumShapesSignal PathwaySignal TransductionSiteSourceStat3 Signaling PathwayStat3 proteinSupportive careTherapeutic InterventionTimeTissuesTranscriptTransgenic MiceTranslatingUrsidae FamilyValidationVisualizationVulnerable PopulationsWeight GainWorkantagonistantibody conjugateburden of illnesscell typecombatcytokineearly detection biomarkersearly onsethigh riskimaging approachimmunological interventionimprovedin vivomacrophagemicrobialmonocytemortalitymortality riskmouse modelneonatal miceneonatal periodneonatal sepsisneonateneutralizing antibodyneutrophilpathogenic bacteriapotential biomarkerpre-clinicalpromoterprophylacticpupreceptor bindingsingle-cell RNA sequencingtargeted treatmenttraffickingwhole animal imaging
项目摘要
PROJECT SUMMARY
Microbial infections are a major cause of infant mortality worldwide. For particularly vulnerable populations
such as pre-term and low birthweight babies, the risk of invasive infections further escalates. The neonatal
period is defined by a distinct, often described as immature, immune system. Many features of a protective
host response to infection are deficient as compared with older children and adults. Our laboratory has
identified that expression of the immune suppressive cytokine interleukin (IL)-27 is elevated in human and
murine neonates. Other recent studies have shown IL-27 to be a biomarker for early onset neonatal sepsis.
This suggests that elevated IL-27 may represent a risk factor and when further increased during bacterial
challenge, compromise the host immune response. The overall premise of the current proposal is that IL-27 is
a host molecule that represents a target for immune intervention to improve the host response and reduce
susceptibility to bacterial infection early in life. We present strong evidence in a mouse model that the absence
of IL-27 signaling translates to increased survival, improved weight gain, and enhanced clearance of bacteria
during neonatal sepsis. To advance our knowledge of how IL-27 regulates the immune response during
neonatal sepsis, we need to identify the complete repertoire of cell types responsible for IL-27 production,
understand how these population may change over the course of infection, and further define their
functionality. We will address this gap in understanding using an IL-27 reporter mouse that expresses a
fluorescent protein under control of the IL-27p28 promoter. Using whole-animal imaging of the reporter mouse
coupled with luminescent bacteria, this will allow us to identify IL-27 producers, sort them for further functional
analysis, and correlate their presence in infected tissues with the bacterial burden. We also seek to understand
cellular signaling pathways required for IL-27-mediated suppressive activity and compromised control of the
bacterial burden. We hypothesize that signal transducer and activator of transcription (Stat)-3 signals
downstream of IL-27 receptor binding to interfere with lysosomal trafficking and acidification. The net result is
compromised bacterial clearance. Lastly, a primary objective is to investigate the outcomes of antagonizing IL-
27 during neonatal sepsis with the aim of establishing an immunotherapeutic approach for an infectious
disease for which we can currently only offer antibiotics and supportive care. Antibiotic resistance confounds
our reliance on this approach. Administration of a neutralizing antibody conjugated to a fluorescent tag will
allow for visualization of tissue penetration in real time and directly correlate the presence of the antagonist
with control of bacterial growth. At the completion of this project, we expect to have performed preclinical
validation of a promising immunotherapeutic approach to improve immunological responses and susceptibility
to infection disease in newborns, as well as provided an enhanced understanding of how IL-27 regulates host
immunity and interactions with bacterial pathogens during neonatal sepsis.
项目摘要
微生物感染是全世界婴儿死亡的主要原因。对于特别脆弱的人群
如早产儿和低出生体重儿,侵入性感染的风险进一步上升。新生儿
这一时期是由一个独特的,通常被描述为不成熟的免疫系统定义的。保护性的许多功能
与年龄较大儿童和成人相比,宿主对感染的反应不足。本实验室
鉴定了免疫抑制细胞因子白细胞介素(IL)-27的表达在人体中升高,
小鼠新生儿。其他最近的研究表明IL-27是早发性新生儿败血症的生物标志物。
这表明升高的IL-27可能是一个危险因素,当在细菌感染期间进一步升高时,
挑战,破坏宿主的免疫反应目前提案的总体前提是IL-27是
宿主分子,其代表免疫干预的靶标,以改善宿主应答并减少
在生命早期易受细菌感染。我们在小鼠模型中提出了强有力的证据,
IL-27信号传导的增加转化为存活率的增加、体重增加的改善和细菌清除的增强。
在新生儿败血症期间。为了进一步了解IL-27如何调节免疫反应,
新生儿败血症,我们需要确定负责IL-27产生的细胞类型的完整库,
了解这些人群在感染过程中如何变化,并进一步确定其
功能.我们将使用IL-27报告小鼠来解决这一理解上的差距,
在IL-27 p28启动子的控制下的荧光蛋白。使用报告小鼠的整体动物成像
再加上发光细菌,这将使我们能够识别IL-27生产者,
分析,并将它们在感染组织中的存在与细菌负荷相关联。我们还试图了解
IL-27介导的抑制活性所需的细胞信号传导途径,以及对
细菌负荷我们假设信号转导子和转录激活子(Stat)-3信号
在IL-27受体结合的下游干扰溶酶体运输和酸化。最终结果是
降低细菌清除率。最后,一个主要目的是研究拮抗IL-10的结果。
27在新生儿败血症期间,目的是建立一种免疫方法,
目前我们只能提供抗生素和支持性治疗。抗生素耐药性混淆
我们对这种方法的依赖。施用缀合至荧光标签的中和抗体将
允许在真实的时间内观察组织渗透
控制细菌生长。在该项目完成时,我们预计已进行临床前研究。
验证一种有前途的免疫学方法,以改善免疫应答和易感性
新生儿感染疾病,以及提供了一个增强的了解IL-27如何调节宿主
新生儿败血症期间的免疫和与细菌病原体的相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cory Michael Robinson其他文献
Cory Michael Robinson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cory Michael Robinson', 18)}}的其他基金
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis
了解 IL-27 作为新生儿败血症期间保护性免疫的负调节因子
- 批准号:
10624257 - 财政年份:2021
- 资助金额:
$ 49.44万 - 项目类别:
Understanding IL-27 as a negative regulator of protective immunity during neonatal sepsis
了解 IL-27 作为新生儿败血症期间保护性免疫的负调节因子
- 批准号:
10278311 - 财政年份:2021
- 资助金额:
$ 49.44万 - 项目类别:
The regulation of early life interleukin-27 expression and metabolic impact
生命早期 IL-27 表达的调节和代谢影响
- 批准号:
10040906 - 财政年份:2020
- 资助金额:
$ 49.44万 - 项目类别:
The regulation of early life interleukin-27 expression and metabolic impact
生命早期 IL-27 表达的调节和代谢影响
- 批准号:
10171779 - 财政年份:2020
- 资助金额:
$ 49.44万 - 项目类别:
Cellular expression and regulation of interleukin-27 in the neonatal immune syste
新生儿免疫系统中白细胞介素27的细胞表达和调节
- 批准号:
8978385 - 财政年份:2014
- 资助金额:
$ 49.44万 - 项目类别:
Cellular expression and regulation of interleukin-27 in the neonatal immune syste
新生儿免疫系统中白细胞介素27的细胞表达和调节
- 批准号:
8890783 - 财政年份:2014
- 资助金额:
$ 49.44万 - 项目类别:
Cellular expression and regulation of interleukin-27 in the neonatal immune syste
新生儿免疫系统中白细胞介素27的细胞表达和调节
- 批准号:
8753444 - 财政年份:2014
- 资助金额:
$ 49.44万 - 项目类别:
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
IL-12和IL-27参与结核分枝杆菌免疫
- 批准号:
8293126 - 财政年份:2011
- 资助金额:
$ 49.44万 - 项目类别:
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
IL-12和IL-27参与结核分枝杆菌免疫
- 批准号:
8528691 - 财政年份:2011
- 资助金额:
$ 49.44万 - 项目类别:
The involvement of IL-12 and IL-27 in immunity to Mycobacterium tuberculosis
IL-12和IL-27参与结核分枝杆菌免疫
- 批准号:
8166093 - 财政年份:2011
- 资助金额:
$ 49.44万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 49.44万 - 项目类别:
Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 49.44万 - 项目类别:
Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 49.44万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 49.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 49.44万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 49.44万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 49.44万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 49.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 49.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 49.44万 - 项目类别:
Grant-in-Aid for Scientific Research (C)